A thorough understanding of the mechanisms underlying the increase in TB-associated cell subsets, such as tissue-resident CD4 T cells and microglia, is expected to lead to new opportunities for therapeutic and diagnostic interventions in TBM. Here, CD4 is linked to meningeal tuberculosis.